Idarucizumab vs Irbesartan

## Idarucizumab vs Irbesartan: Overview

This comparison examines the pharmacological differences between **Idarucizumab** and **Irbesartan**.

## Mechanism of Action

**Irbesartan**: Selective non-competitive angiotensin II type 1 receptor antagonist.

## Pharmacokinetics

**Half-life**: Idarucizumab — N/A; Irbesartan — 11-15 hours.

## Chemical Properties

**Molecular Formula**: Idarucizumab — N/A; Irbesartan — C25H28N6O.

**Molecular Weight**: Idarucizumab — N/A; Irbesartan — 428.5320 g/mol.

**Type**: Idarucizumab — Antibody; Irbesartan — Small molecule.